Evidence supporting the use of: Myoviridae
For the health condition: Blood Poisoning

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Myoviridae is a family of bacteriophages (viruses that infect bacteria) and has been studied as a potential therapy for blood poisoning, also known as sepsis, particularly when caused by antibiotic-resistant bacteria. The scientific rationale is that bacteriophages can specifically target and lyse bacterial pathogens, reducing bacterial load in the bloodstream. This approach, known as phage therapy, has historical roots dating back to the early 20th century but has seen renewed interest due to rising antibiotic resistance.

Recent preclinical studies and limited clinical case reports have demonstrated that Myoviridae phages can be effective against pathogens such as Escherichia coli and Pseudomonas aeruginosa in sepsis models. For example, animal studies have shown improved survival and decreased bacterial counts following phage administration. There are also isolated case reports of successful phage therapy in humans with multidrug-resistant bloodstream infections. However, large-scale randomized controlled trials are still lacking, and the regulatory pathway for such treatments is evolving.

In summary, while there is a growing body of scientific evidence—mostly preclinical and early clinical—to support the use of Myoviridae phages for treating blood poisoning, the evidence base is not yet robust. Therefore, its current rating is moderate (3/5), reflecting promising but preliminary support for this therapeutic approach.

More about Myoviridae
More about Blood Poisoning

Products containing Myoviridae

We currently have no products on Caring Sunshine that contain this ingredient.